US RE50,634 E1
Diaryl macrocycles as modulators of protein kinases
Jingrong Jean Cui, Princeton, NJ (US); Yishan Li, Princeton, NJ (US); Evan W. Rogers, Princeton, NJ (US); and Dayong Zhai, Princeton, NJ (US)
Assigned to Turning Point Therapeutics, Inc., Princeton, NJ (US)
Appl. No. 18/147,888
Filed by Turning Point Therapeutics, Inc., Princeton, NJ (US)
PCT Filed Jan. 23, 2015, PCT No. PCT/US2015/012597
§ 371(c)(1), (2) Date Jul. 22, 2016,
PCT Pub. No. WO2015/112806, PCT Pub. Date Jul. 30, 2015.
Application 18/147,888 is a reissue of application No. 15/113,583, filed on Jan. 23, 2015, granted, now 9,714,258, issued on Jul. 25, 2017.
Claims priority of provisional application 62/106,301, filed on Jan. 22, 2015.
Claims priority of provisional application 62/049,326, filed on Sep. 11, 2014.
Claims priority of provisional application 61/931,506, filed on Jan. 24, 2014.
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 498/18 (2006.01)
CPC C07D 498/18 (2013.01) [C07B 2200/13 (2013.01)] 23 Claims
 
[ 23. A compound of the formula

OG Complex Work Unit Chemistry
]